373 related articles for article (PubMed ID: 21443201)
1. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
Pan S; Chen R; Crispin DA; May D; Stevens T; McIntosh MW; Bronner MP; Ziogas A; Anton-Culver H; Brentnall TA
J Proteome Res; 2011 May; 10(5):2359-76. PubMed ID: 21443201
[TBL] [Abstract][Full Text] [Related]
2. Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.
Capello M; Bantis LE; Scelo G; Zhao Y; Li P; Dhillon DS; Patel NJ; Kundnani DL; Wang H; Abbruzzese JL; Maitra A; Tempero MA; Brand R; Firpo MA; Mulvihill SJ; Katz MH; Brennan P; Feng Z; Taguchi A; Hanash SM
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376157
[TBL] [Abstract][Full Text] [Related]
3. Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study.
Pan S; Chen R; Brand RE; Hawley S; Tamura Y; Gafken PR; Milless BP; Goodlett DR; Rush J; Brentnall TA
J Proteome Res; 2012 Mar; 11(3):1937-48. PubMed ID: 22316387
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis.
Nie S; Lo A; Wu J; Zhu J; Tan Z; Simeone DM; Anderson MA; Shedden KA; Ruffin MT; Lubman DM
J Proteome Res; 2014 Apr; 13(4):1873-84. PubMed ID: 24571389
[TBL] [Abstract][Full Text] [Related]
5. Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis.
Saraswat M; Joenväärä S; Seppänen H; Mustonen H; Haglund C; Renkonen R
Cancer Med; 2017 Jul; 6(7):1738-1751. PubMed ID: 28573829
[TBL] [Abstract][Full Text] [Related]
6. Proteomics as a systems approach to pancreatitis.
Williams JA
Pancreas; 2013 Aug; 42(6):905-11. PubMed ID: 23851428
[TBL] [Abstract][Full Text] [Related]
7. Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics.
Yoneyama T; Ohtsuki S; Honda K; Kobayashi M; Iwasaki M; Uchida Y; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Huang W; Yamada T; Tachikawa M; Terasaki T
PLoS One; 2016; 11(8):e0161009. PubMed ID: 27579675
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer.
Chen R; Brentnall TA; Pan S; Cooke K; Moyes KW; Lane Z; Crispin DA; Goodlett DR; Aebersold R; Bronner MP
Mol Cell Proteomics; 2007 Aug; 6(8):1331-42. PubMed ID: 17496331
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method.
Nie S; Yin H; Tan Z; Anderson MA; Ruffin MT; Simeone DM; Lubman DM
J Proteome Res; 2014 Dec; 13(12):6058-66. PubMed ID: 25393578
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of formalin-fixed paraffin-embedded pancreatic tissue using liquid chromatography tandem mass spectrometry.
Paulo JA; Lee LS; Banks PA; Steen H; Conwell DL
Pancreas; 2012 Mar; 41(2):175-85. PubMed ID: 22015969
[TBL] [Abstract][Full Text] [Related]
11. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue.
Zhou Q; Andersson R; Hu D; Bauden M; Kristl T; Sasor A; Pawłowski K; Pla I; Hilmersson KS; Zhou M; Lu F; Marko-Varga G; Ansari D
EBioMedicine; 2019 May; 43():282-294. PubMed ID: 30982764
[TBL] [Abstract][Full Text] [Related]
13. Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9.
Koopmann J; Rosenzweig CN; Zhang Z; Canto MI; Brown DA; Hunter M; Yeo C; Chan DW; Breit SN; Goggins M
Clin Cancer Res; 2006 Jan; 12(2):442-6. PubMed ID: 16428484
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.
Kuhlmann KF; van Till JW; Boermeester MA; de Reuver PR; Tzvetanova ID; Offerhaus GJ; Ten Kate FJ; Busch OR; van Gulik TM; Gouma DJ; Crawford HC
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):886-91. PubMed ID: 17507610
[TBL] [Abstract][Full Text] [Related]
15. Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer.
Nigjeh EN; Chen R; Allen-Tamura Y; Brand RE; Brentnall TA; Pan S
Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28627758
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
Tian M; Cui YZ; Song GH; Zong MJ; Zhou XY; Chen Y; Han JX
BMC Cancer; 2008 Aug; 8():241. PubMed ID: 18706098
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of pancreatic cancer for biomarker discovery.
Chen R; Pan S; Brentnall TA; Aebersold R
Mol Cell Proteomics; 2005 Apr; 4(4):523-33. PubMed ID: 15684406
[TBL] [Abstract][Full Text] [Related]
18. Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.
Prokopchuk O; Grünwald B; Nitsche U; Jäger C; Prokopchuk OL; Schubert EC; Friess H; Martignoni ME; Krüger A
BMC Cancer; 2018 Feb; 18(1):128. PubMed ID: 29394913
[TBL] [Abstract][Full Text] [Related]
19. A mouse to human search for plasma proteome changes associated with pancreatic tumor development.
Faca VM; Song KS; Wang H; Zhang Q; Krasnoselsky AL; Newcomb LF; Plentz RR; Gurumurthy S; Redston MS; Pitteri SJ; Pereira-Faca SR; Ireton RC; Katayama H; Glukhova V; Phanstiel D; Brenner DE; Anderson MA; Misek D; Scholler N; Urban ND; Barnett MJ; Edelstein C; Goodman GE; Thornquist MD; McIntosh MW; DePinho RA; Bardeesy N; Hanash SM
PLoS Med; 2008 Jun; 5(6):e123. PubMed ID: 18547137
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
